Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Dyspnea
- Hypercapnia
- Respiratory Insufficiency
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: None (Open Label)Masking Description: This trial is non-blinded by necessity, as there are distinct differences in size and appearance between the new and current HVNI device designs.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The objective of this study is to evaluate the ability of a new HVNI device to improve ventilation, dyspnea, and related physiological responses relative to the conventional Precision Flow device design, with which there are published clinical outcomes data. It is hypothesized that the new HVNI devi...
The objective of this study is to evaluate the ability of a new HVNI device to improve ventilation, dyspnea, and related physiological responses relative to the conventional Precision Flow device design, with which there are published clinical outcomes data. It is hypothesized that the new HVNI device design (V2.0) will be comparable at relieving patient dyspnea when compared to the conventional HVNI device design (Precision Flow).
Tracking Information
- NCT #
- NCT04590014
- Collaborators
- VA Pittsburgh Healthcare System
- Investigators
- Principal Investigator: Charles Atwood VA Pittsburgh Healthcare System
Get Well Soon